Marcel Keller - Department Biology I, Ludwig-Maximilians-University Munich

基本信息

Career Trajectory

Bio

Marcel Keller is a Postdoc at the Institute of Genomics, University of Tartu, Estonia, and Integrative Prehistory and Archeological Science, University of Basel, Switzerland.

Research Interests

Papers共 59 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

Probing the Zooarchaeological Record Across Time and Space for Ancient Pathogens

Anne K. W. Runge, Ian Light-Maka,Ken Massy,Marcel Keller,Simon Trixl, Helja Kabral, Casey L. Kirkpatrick,Kirsten Bos,Jana Eger,Michal Ernée,René Kyselý,Michael Hochmuth,Dominik Poradowski,Aleksander Chrószcz,Norbert Benecke,David Daněček, Jana Klementová, Anatoli Nagler,Alexey A. Kalmykov,Anatoly R. Kantorovich,Vladimir E. Maslov,Andrey B. Belinskiy, Christina L. Scheib,Meda Toderaş,Svend Hansen,Philipp W. Stockhammer,Kai Kaniuth,Regina Uhl,Sabine Reinhold, Rosalind E. Gillis,Elizabeth A. Nelson,Kamilla Pawlowska,Felix M. Key

biorxiv（2025）

Cited0Views0Bibtex

Discovery of the Clinical Candidate IDOR-1117-2520: A Potent and Selective Antagonist of CCR6 for Autoimmune Diseases

Emmanuel A. Meyer,Andrew L. Croxford,Carmela Gnerre,Paulina Kulig,Mark J. Murphy, Elise M. Jacob,Gabriel Schafer,Sylvia Richard-Bildstein,Hamed Aissaoui,Patrick Bouis,Eric A. Ertel,Ruben de Kanter,Marcel P. Keller, Urs Luthi,Eva Caroff

Journal of Medicinal Chemistryno. 10 (2024): 8077-8098

Cited2Views0WOSBibtex

A Refined Phylochronology of the Second Plague Pandemic in Western Eurasia

openalex（2023）

Cited4Views0Bibtex

Ancient DNA Extract Purification (chunk Samples/high Volume) V1

Marcel Keller

openalex（2023）

Cited0Views0Bibtex

Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies

Emmanuel A. Meyer,Paivi Aanismaa,Eric A. Ertel, Eva Huhn,Daniel S. Strasser,Markus Rey,Mark J. Murphy,Marianne M. Martinic,Laetitia Pouzol,Sylvie Froidevaux,Marcel P. Keller,Eva Caroff

Journal of medicinal chemistry（2023）

Cited4Views0WOSBibtex

Design, Synthesis, and Pharmacological Evaluation of Benzimidazolo-thiazoles As Potent CXCR3 Antagonists with Therapeutic Potential in Autoimmune Diseases: Discovery of ACT-672125

Eva Caroff,Emmanuel A. Meyer,Paeivi Aanismaa,Sylvie Froidevaux,Marcel Keller,Luca Piali

JOURNAL OF MEDICINAL CHEMISTRY（2022）

Cited3Views0WOSBibtex

Dining in Tuva: Social Correlates of Diet and Mobility in Southern Siberia During the 2nd–4th Centuries CE

Marco Milella,Gino Caspari,Zita Laffranchi,Gabriele Arenz,Timur Sadykov,Jegor Blochin,Marcel Keller,Yulija Kapinus,Sandra Losch

American Journal of Physical Anthropologyno. 1 (2022): 124-139

Cited6Views0Bibtex

Rekonstruktion Mikrobieller Evolution Durch Sequenzierung Alter DNA

Guellil Meriam,Keller Marcel

BIOspektrumno. 3 (2022): 287-290

Cited0Views0Bibtex

In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P1) Expression and Mediated Migration of Primary Human T and B Cells in the Context of Cenerimod, a Novel, Selective S1P1 Receptor Modulator

Lisa Schlicher,Paulina Kulig, Audrey von Munchow,Mark J. Murphy,Marcel P. Keller

International Journal of Molecular Sciences（2022）

Cited2Views0WOSBibtex

Discovery and in Vivo Evaluation of ACT-660602: A Potent and Selective Antagonist of the Chemokine Receptor CXCR3 for Autoimmune Diseases

Emmanuel A. Meyer,Paeivi Aanismaa,Sylvie Froidevaux,Marcel Keller,Luca Piali,Eva Caroff

JOURNAL OF MEDICINAL CHEMISTRY（2022）

Cited2Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn